Manufacturer of Controlled Substances; Notice of Application, 72973-72974 [2011-30542]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 228 / Monday, November 28, 2011 / Notices
To
receive a copy of the information
collection request contact John Trelease,
at (202) 208–2783, or by email at
jtrelease@osmre.gov.
SUPPLEMENTARY INFORMATION: The Office
of Management and Budget (OMB)
regulations at 5 CFR part 1320, which
implement provisions of the Paperwork
Reduction Act of 1995 (Pub. L. 104–13),
require that interested members of the
public and affected agencies have an
opportunity to comment on information
collection and recordkeeping activities
[see 5 CFR 1320.8 (d)]. This notice
identifies an information collection that
OSM will be submitting to OMB for
renewed approval. This collection is
contained in 30 CFR parts 779 and
783—Surface and Underground Mining
Permit Applications—Minimum
Requirements for Information on
Environmental Resources. OSM will
request a 3-year term of approval for this
information collection activity.
An agency may not conduct or
sponsor, and a person is not required to
respond to a collection of information
unless it displays a currently valid OMB
control number. The OMB control
number for parts 779 and 783 is 1029–
0035. Responses are required to obtain
a benefit for this collection.
OSM has revised burden estimates,
where appropriate, to reflect current
reporting levels or adjustments based on
Creestimates of burden on respondents
and costs.
Comments are invited on: (1) The
need for the collection of information
for the performance of the functions of
the agency; (2) the accuracy of the
agency’s burden estimates; (3) ways to
enhance the quality, utility and clarity
of the information collection; and (4)
ways to minimize the information
collection burden on respondents, such
as use of automated means of collection
of the information. A summary of the
public comments will accompany
OSM’s submission of the information
collection request to OMB.
Before including your address, phone
number, email address, or other
personal identifying information in your
comment, you should be aware that
your entire comment—including your
personal identifying information—may
be made publicly available at any time.
While you can ask us in your comment
to withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
This notice provides the public with
60 days in which to comment on the
following information collection
activity:
pmangrum on DSK3VPTVN1PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
VerDate Mar<15>2010
15:34 Nov 25, 2011
Jkt 226001
Title: 30 CFR Parts 779 and 783—
Surface and Underground Mining
Permit Applications—Minimum
Requirements for Environmental
Resources.
OMB Control Number: 1029–0035.
Summary: Applicants for surface and
underground coal mining permits are
required to provide adequate
descriptions of the environmental
resources that may be affected by
proposed mining activities. The
information will be used by the
regulatory authority to determine if the
applicant can comply with
environmental protection performance
standards.
Bureau Form Number: None.
Frequency of Collection: Once.
Description of Respondents: 219 coal
mining operators and 24 state regulatory
authorities.
Total Annual Responses: 2,175.
Total Annual Burden Hours: 188,816.
Total Annual Non-Wage Burden Cost:
$0.
Dated: November 18, 2011.
Stephen M. Sheffield,
Acting Chief, Division of Regulatory Support.
[FR Doc. 2011–30345 Filed 11–25–11; 8:45 am]
BILLING CODE 4310–05–M
DEPARTMENT OF JUSTICE
Notice of Lodging of Consent Decree
Under the Clean Water Act and Safe
Drinking Water Act
Notice is hereby given that on
November 21, 2011, a proposed Consent
Decree (‘‘proposed Decree’’) in United
States, et al. v. Town of Fort Gay, Civil
Action No. 3:09–0855 was lodged with
the United States District Court for the
Southern District of West Virginia.
On September 21, 2009, the United
States and the West Virginia Department
of Environmental Protection and West
Virginia Department of Health and
Human Resources (collectively,
‘‘Plaintiffs’’) filed a complaint against
the Town of Fort Gay, West Virginia
(‘‘Defendant’’ or ‘‘Fort Gay’’) for
permanent injunctive relief and civil
penalties under the Clean Water Act, 33
U.S.C. 1251–387; the Safe Drinking
Water Act, 42 U.S.C. 300f–300j–26; the
West Virginia Water Pollution Control
Act, W.Va Code § 22–11–22; and
Chapter 16, Article I, Section 9a of the
West Virginia Code.
The proposed Decree requires
Defendant to comply with certain
permit requirements, to prepare and
submit certain reports, to make capital
improvements to the Fort Gay waste
water collection and treatment system
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
72973
and drinking water treatment system
(collectively, the ‘‘Facilities’’), and to
improve staffing at the Facilities. The
proposed Decree appoints the County
Commission of Wayne County, West
Virginia as Receiver of the Facilities.
The Department of Justice will receive
for a period of thirty (30) days from the
date of this publication comments
relating to the proposed Decree.
Comments should be addressed to the
Assistant Attorney General,
Environment and Natural Resources
Division, and either emailed to
pubcomment-ees.enrd@USDOJ.gov or
mailed to P.O. Box 7611, U.S.
Department of Justice, Washington, DC
20044–7611, and should refer to United
States, et al. v. Town of Fort Gay, D.J.
Ref. 90–5–1–1–09447.
During the public comment period,
the proposed Decree may be examined
on the following Department of Justice
Web site: https://www.usdoj.gov/enrd/
Consent_Decrees.html. A copy of the
proposed Decree may also be obtained
by mail from the Consent Decree
Library, P.O. Box 7611, U.S. Department
of Justice, Washington, DC 20044–7611,
or by faxing or emailing a request to
Tonia Fleetwood:
Tonia.Fleetwood@USDOJ.gov, fax no.
(202) 514–0097, phone confirmation
number: (202) 514–1547. In requesting a
copy from the Consent Decree Library,
please enclose a check in the amount of
$20.75 (25 cents per page reproduction
cost) payable to the U.S. Treasury or, if
by email or fax, please forward a check
in that amount to the Consent Decree
Library at the stated address.
Robert Brook,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2011–30422 Filed 11–25–11; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on July 18, 2011,
Aldrich Chemical Company Inc., DBA
Isotec, 3858 Benner Road, Miamisburg,
Ohio 45342–4304, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
E:\FR\FM\28NON1.SGM
28NON1
72974
Federal Register / Vol. 76, No. 228 / Monday, November 28, 2011 / Notices
Drug
Gamma
Hydroxybutyric
Acid
(2010).
Methaqualone (2565) ...................
Ibogaine (7260) ............................
Tetrahydrocannabinols (7370) .....
2,5-Dimethoxyamphetamine
(7396).
Psilocyn (7438) .............................
Normorphine (9313) .....................
Acetylmethadol (9601) .................
Alphacetylmethadol except levo–
alphacetylmethadol (9603).
Normethadone (9635) ..................
Norpipanone (9636) .....................
3-Methylfentanyl (9813) ................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
1-Phenylcyclohexylamine (7460)
Phencyclidine (7471) ....................
Phenylacetone (8501) ..................
1Piperidinocyclohexanecarbonitrile (8603).
Cocaine (9041) .............................
Codeine (9050) .............................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Benzoylecgonine (9180) ...............
Ethylmorphine (9190) ...................
Hydrocodone (9193) .....................
Isomethadone (9226) ...................
Meperidine (9230) ........................
Meperidine intermediate-A (9232)
Meperidine intermediate-B (9233)
Methadone (9250) ........................
Methadone intermediate (9254) ...
Dextropropoxyphene, bulk, (nondosage forms) (9273).
Morphine (9300) ...........................
Thebaine (9333) ...........................
Levo-alphacetylmethadol (9648) ..
Oxymorphone (9652) ...................
pmangrum on DSK3VPTVN1PROD with NOTICES
I
I
I
I
I
Dated: November 18, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than January 27, 2012.
[FR Doc. 2011–30542 Filed 11–25–11; 8:45 am]
Dated: November 18, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Schedule
BILLING CODE 4410–09–P
I
I
I
I
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances Notice of Application
II
II
II
II
II
II
II
II
II
II
II
II
II
II
15:34 Nov 25, 2011
II
II
II
II
Jkt 226001
DEPARTMENT OF JUSTICE
Drug
The company plans to manufacture
small quantities of the listed controlled
substances to produce isotope labeled
standards for drug testing and analysis.
In reference to drug code 7370 the
company plans to bulk manufacture a
synthetic Tetrahydrocannabinol. No
other activity for this drug code is
authorized for this registration.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than January 27, 2012.
VerDate Mar<15>2010
BILLING CODE 4410–09–P
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on September 9, 2011,
Johnson Matthey Inc., Custom
Pharmaceuticals Department, 2003
Nolte Drive, West Deptford, New Jersey
08066–1742, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
I
I
I
II
II
II
II
II
II
II
II
II
II
[FR Doc. 2011–30551 Filed 11–25–11; 8:45 am]
Schedule
Gamma
Hydroxybutyric
Acid
(2010).
Tetrahydrocannabinols (7370) .....
Dihydromorphine (9145) ...............
Difenoxin (9168) ...........................
Propiram (9649) ...........................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Lisdexamfetamine (1205) .............
Methylphenidate (1724) ................
Nabilone (7379) ............................
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Diphenoxylate (9170) ...................
Ecgonine (9180) ...........................
Hydrocodone (9193) .....................
Meperidine (9230) ........................
Methadone (9250) ........................
Methadone intermediate (9254) ...
Morphine (9300) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ...................
Noroxymorphone (9668) ..............
Alfentanil (9737) ...........................
Remifentanil (9739) ......................
Sufentanil (9740) ..........................
Fentanyl (9801) ............................
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for sale to its customers.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
Drug Enforcement Administration
Manufacturer of Controlled
Substances Notice of Application
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on September 15,
2011, Johnson Matthey Pharmaceutical
Materials Inc., Pharmaceutical Service,
25 Patton Road, Devens, Massachusetts
01434, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
Drug
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Nabilone (7379) ............................
Hydrocodone (9193) .....................
Alfentanil (9737) ...........................
Remifentanil (9739) ......................
Sufentanil (9740) ..........................
Schedule
II
II
II
II
II
II
II
The company plans to utilize this
facility to manufacture small quantities
of the listed controlled substances in
bulk and to conduct analytical testing in
support of the company’s primary
manufacturing facility in West Deptford,
New Jersey. The controlled substances
manufactured in bulk at this facility will
be distributed to the company’s
customers.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than January 27, 2012.
E:\FR\FM\28NON1.SGM
28NON1
]]>Agencies
[Federal Register Volume 76, Number 228 (Monday, November 28, 2011)]
[Notices]
[Pages 72973-72974]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-30542]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal
Regulations (CFR), this is notice that on July 18, 2011, Aldrich
Chemical Company Inc., DBA Isotec, 3858 Benner Road, Miamisburg, Ohio
45342-4304, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the
following basic classes of controlled substances:
[[Page 72974]]
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)........... I
Methaqualone (2565)........................ I
Ibogaine (7260)............................ I
Tetrahydrocannabinols (7370)............... I
2,5-Dimethoxyamphetamine (7396)............ I
Psilocyn (7438)............................ I
Normorphine (9313)......................... I
Acetylmethadol (9601)...................... I
Alphacetylmethadol except levo- I
alphacetylmethadol (9603).
Normethadone (9635)........................ I
Norpipanone (9636)......................... I
3-Methylfentanyl (9813).................... I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Methylphenidate (1724)..................... II
Amobarbital (2125)......................... II
Pentobarbital (2270)....................... II
Secobarbital (2315)........................ II
1-Phenylcyclohexylamine (7460)............. II
Phencyclidine (7471)....................... II
Phenylacetone (8501)....................... II
1-Piperidinocyclohexanecarbonitrile (8603). II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Benzoylecgonine (9180)..................... II
Ethylmorphine (9190)....................... II
Hydrocodone (9193)......................... II
Isomethadone (9226)........................ II
Meperidine (9230).......................... II
Meperidine intermediate-A (9232)........... II
Meperidine intermediate-B (9233)........... II
Methadone (9250)........................... II
Methadone intermediate (9254).............. II
Dextropropoxyphene, bulk, (non-dosage II
forms) (9273).
Morphine (9300)............................ II
Thebaine (9333)............................ II
Levo-alphacetylmethadol (9648)............. II
Oxymorphone (9652)......................... II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the listed
controlled substances to produce isotope labeled standards for drug
testing and analysis.
In reference to drug code 7370 the company plans to bulk
manufacture a synthetic Tetrahydrocannabinol. No other activity for
this drug code is authorized for this registration.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than January 27, 2012.
Dated: November 18, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-30542 Filed 11-25-11; 8:45 am]
BILLING CODE 4410-09-P
